-
EP1077948
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1077948
| EP1077948 - NOVEL 1,2,5-TRISUBSTITUTED 1,2-DIHYDRO-INDAZOL-3-ONES WITH ANTI-ASTHMATIC, ANTI-ALLERGIC, ANTI-INFLAMMATORY, IMMUNO-MODULATING AND NEURO-PROTECTIVE EFFECT, METHOD FOR THE PRODUCTION AND USE THEREOF AS A MEDICAMENT [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 26.12.2003 Database last updated on 06.07.2024 | Most recent event Tooltip | 20.11.2009 | Change - representative | published on 23.12.2009 [2009/52] | Applicant(s) | For all designated states ARZNEIMITTELWERK DRESDEN GmbH Meissner Strasse 35 01445 Radebeul / DE | [N/P] |
| Former [2001/09] | For all designated states Arzneimittelwerk Dresden GmbH Meissner Strasse 35 01445 Radebeul / DE | Inventor(s) | 01 /
SCHINDLER, Rudolf Pirnaer Landstrasse 146 D-01257 Dresden / DE | 02 /
HÖFGEN, Norbert Hufenweg 1 D-01458 Medingen / DE | 03 /
POPPE, Hildegard Kieler Strasse 6 D-01109 Dresden / DE | 04 /
BRUNE, Kay Weiherackerweg 17 D-91080 Marloffstein / DE | [2001/09] | Representative(s) | Böhm, Brigitte, et al Weickmann & Weickmann Patent- und Rechtsanwälte PartmbB Postfach 860 820 81635 München / DE | [N/P] |
| Former [2009/52] | Böhm, Brigitte, et al Weickmann & Weickmann Patentanwälte Postfach 86 08 20 81635 München / DE | ||
| Former [2001/21] | Böhm, Brigitte, Dipl.-Chem. Dr., et al Weickmann & Weickmann Patentanwälte Postfach 86 08 20 81635 München / DE | Application number, filing date | 99950343.6 | 01.04.1999 | [2001/09] | WO1999EP02291 | Priority number, date | DE1998121003 | 11.05.1998 Original published format: DE 19821003 | [2001/09] | Filing language | DE | Procedural language | DE | Publication | Type: | A1 Application with search report | No.: | WO9958504 | Date: | 18.11.1999 | Language: | DE | [1999/46] | Type: | A1 Application with search report | No.: | EP1077948 | Date: | 28.02.2001 | Language: | DE | The application published by WIPO in one of the EPO official languages on 18.11.1999 takes the place of the publication of the European patent application. | [2001/09] | Search report(s) | International search report - published on: | EP | 18.11.1999 | Classification | IPC: | C07D231/56, C07D417/06, C07D403/06, A61K31/415, A61K31/425, A61K31/495 | [2001/09] | CPC: |
C07D231/56 (EP,KR,US);
A61P11/06 (EP);
A61P25/00 (EP);
A61P25/16 (EP);
A61P25/28 (EP);
A61P29/00 (EP);
A61P37/02 (EP);
A61P37/08 (EP);
A61P43/00 (EP);
C07D235/26 (KR);
C07D277/22 (KR);
C07D295/135 (KR);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2001/09] | Extension states | LT | 28.10.2000 | LV | 28.10.2000 | MK | 28.10.2000 | RO | 28.10.2000 | SI | 28.10.2000 | Title | German: | NEUE 1,2,5-TRISUBSTITUIERTE 1,2-DIHYDRO-INDAZOL-3-ONE MIT ANTIASTHMATISCHER, ANTIALLERGISCHER, ENTZÜNDUNGSHEMMENDER, IMMUNMODULIERENDER UND NEUROPROTEKTIVER WIRKUNG, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS ARZNEIMITTEL | [2001/09] | English: | NOVEL 1,2,5-TRISUBSTITUTED 1,2-DIHYDRO-INDAZOL-3-ONES WITH ANTI-ASTHMATIC, ANTI-ALLERGIC, ANTI-INFLAMMATORY, IMMUNO-MODULATING AND NEURO-PROTECTIVE EFFECT, METHOD FOR THE PRODUCTION AND USE THEREOF AS A MEDICAMENT | [2001/09] | French: | NOUVELLES 1,2-DIHYDRO-INDAZOL-3-ONES TRISUBSTITUEES AUX POSITIONS 1,2,5, A EFFET ANTI-ASTHMATIQUE, ANTI-ALLERGIQUE, ANTI-INFLAMMATOIRE, IMMUNOMODULATEUR ET NEUROPROTECTEUR, LEUR PROCEDE DE PRODUCTION ET LEUR UTILISATION COMME MEDICAMENT | [2001/09] | Entry into regional phase | 28.10.2000 | National basic fee paid | 28.10.2000 | Designation fee(s) paid | 28.10.2000 | Examination fee paid | Examination procedure | 19.04.1999 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 28.10.2000 | Examination requested [2001/09] | 18.01.2002 | Amendment by applicant (claims and/or description) | 27.03.2003 | Despatch of a communication from the examining division (Time limit: M04) | 07.08.2003 | Application deemed to be withdrawn, date of legal effect [2004/07] | 11.09.2003 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2004/07] | Fees paid | Renewal fee | 30.04.2001 | Renewal fee patent year 03 | 28.03.2002 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 30.04.2003 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [DA]EP0072961 (KALI CHEMIE PHARMA GMBH [DE]) [DA] 1,3-5,7-10 * abstract ** page 18 - page 19; example 1 *; | [DA]EP0284174 (ICI PLC [GB], et al) [DA] 1,3-5,7-10 * abstract * * page 52 - page 57; example - *; | [A]EP0355970 (ICI PLC [GB], et al) [A] 1,3-5,7-10 * abstract * * page 10 - page 13; example - *; | [A]WO9734874 (DRESDEN ARZNEIMITTEL [DE]) [A] 1,3-5,7-10 * abstract * * page 21 - page 22 * * page 30 *; | [X] - MALAMAS M S ET AL, "Quinazolineacetic acids and related analogs as aldose reductase inhibitors", J. MED. CHEM. (JMCMAR,00222623);1991; VOL.34 (4); PP.1492-503, Wyeth-Ayerst Res.;Princeton; 08543-8000; NJ; USA (US), XP002117660 [X] 1 * page 1498; example 66; table VI * DOI: http://dx.doi.org/10.1021/jm00108a038 |